鲑鱼降钙素与基础药物治疗骨质疏松疗效分析

Efficacy of salmon calcitonin and basic drugs in the treatment of osteoporosis

目的研究老年骨质疏松患者采用基础治疗并加用鲑鱼降钙素的临床疗效。方法选取2015年10月-2016年10月湖北医药学院附属人民医院收治的骨质疏松老年患者68例为研究对象,将其随机分为对照组和研究组各34例,两组患者均给予基础治疗,研究组加服鲑鱼降钙素,观察两组疗效。结果治疗后,研究组总有效率为88.2%,明显高于对照组的73.5%,差异有统计学意义(P<0.05)。研究组治疗后BMD较治疗前明显增加,差异有统计学意义(P<0.05);对照组治疗后BMD较治疗前比较,差异无统计学意义(P>0.05)。结论采用鲑鱼降钙素能明显提高老年骨质疏松患者的骨密度,缓解患者疼痛症状,疗效确切,值得推广。

Objective To study the clinical efficacy of basic treatment and salmon calcitonin in elderly patients with osteoporosis. Methods 6 8 elderly patients with osteoporosis were enrolled in Affiliated People＇s Hospital of Hubei M edical College from October 2 015 to October 2 016. The patients were randomly divided into control group and study group with 34 cases in each group. Patients were given basic treatment,the study group was given additional salmon calcitonin. The curative effect of the 2 groups was observed.Results After treatment,the total effective rate of the study group with 88.2 % was significantly higher than that of the control group with 73. 5 %,the difference was statistically significant（P〈0. 05）. BM D in the study group after treatment increased significantly compared with that before treatment,the difference was statistically significant（P 〈0. 05）. BM D in the control group after treatment compared had no significant difference with that before treatment（P〉0. 05）. Conclusion Salmon calcitonin can significantly improve the BM D of elderly patients with osteoporosis and relieve the pain symptoms of patients. The curative effect is exact and worthy of promotion.